Blue Ridge Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,338,300	Closed	-$170M	–	2
2017 Q4	$170M	Sell	1,338,300 -193,599	-13%	-$24.3M	5.66%	6
2017 Q3	$180M	Buy	1,531,899 +155,199	+11%	+$13.2M	3.23%	15
2017 Q2	$110M	Sell	1,376,700 -213,300	-13%	-$13.6M	1.92%	23
2017 Q1	$81.5M	Buy	1,590,000 +270,000	+20%	+$12.5M	1.06%	32
2016 Q4	$49.4M	Hold	1,320,000	–	–	0.62%	39
2016 Q3	$89.5M	Hold	1,320,000	–	–	1.06%	33
2016 Q2	$73.2M	Buy	1,320,000 +245,000	+23%	+$15.4M	0.95%	34
2016 Q1	$67.5M	Hold	1,075,000	–	–	0.85%	37
2015 Q4	$101M	Hold	1,075,000	–	–	1.13%	36
2015 Q3	$86.4M	Hold	1,075,000	–	–	0.99%	40
2015 Q2	$129M	Buy	1,075,000 +115,000	+12%	+$13.7M	1.45%	35
2015 Q1	$100M	Buy	960,000 +530,000	+123%	+$53.7M	1.14%	34
2014 Q4	$41.7M	Buy	+430,000	New	+$39.8M	0.51%	42